Cargando…

Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule

BACKGROUND: Major depressive disorder (MDD) is often handled as an episodic and isolated disorder, resulting in an optimistic view about its prognosis. Herein, we test the idea that the prognosis of MDD changes if we vary the perspective in terms of (1) a longer time frame and (2) a broader diagnost...

Descripción completa

Detalles Bibliográficos
Autores principales: Verduijn, Judith, Verhoeven, Josine E., Milaneschi, Yuri, Schoevers, Robert A., van Hemert, Albert M., Beekman, Aartjan T. F., Penninx, Brenda W. J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725897/
https://www.ncbi.nlm.nih.gov/pubmed/29228943
http://dx.doi.org/10.1186/s12916-017-0972-8
_version_ 1783285628555755520
author Verduijn, Judith
Verhoeven, Josine E.
Milaneschi, Yuri
Schoevers, Robert A.
van Hemert, Albert M.
Beekman, Aartjan T. F.
Penninx, Brenda W. J. H.
author_facet Verduijn, Judith
Verhoeven, Josine E.
Milaneschi, Yuri
Schoevers, Robert A.
van Hemert, Albert M.
Beekman, Aartjan T. F.
Penninx, Brenda W. J. H.
author_sort Verduijn, Judith
collection PubMed
description BACKGROUND: Major depressive disorder (MDD) is often handled as an episodic and isolated disorder, resulting in an optimistic view about its prognosis. Herein, we test the idea that the prognosis of MDD changes if we vary the perspective in terms of (1) a longer time frame and (2) a broader diagnostic conceptualisation including dysthymia, (hypo)mania and anxiety disorders as relevant outcomes. METHODS: Patients with current MDD at baseline (n = 903) and available 2-, 4-, and/or 6-year follow-up assessments were selected from the Netherlands Study of Depression and Anxiety, a psychiatric cohort study. Combining psychiatric DSM-IV-based diagnoses and life-chart data, patient course trajectories were classified as (1) recovered (no diagnoses at 2-year follow-up or thereafter), (2) recurrent without chronic episodes, (3) recurrent with chronic episodes or (4) consistently chronic since baseline. A chronic episode was defined as having a current diagnosis at the follow-up assessment and consistent symptoms over 2 years. Proportions of course trajectories were provided moving from a short, narrow perspective (2-year follow-up, considering only MDD diagnosis) to a long, broad perspective (6-year follow-up, including MDD, dysthymia, (hypo)mania and anxiety diagnoses). RESULTS: With the short, narrow perspective, the recovery rate was 58% and 21% had a chronic episode. However, in the long, broad perspective the recovery rate was reduced to 17%, while 55% of the patients experienced chronic episodes. CONCLUSIONS: Results from a long and rigorous follow-up in a large cohort suggests that most MDD patients have an unfavourable prognosis. Longer follow-up and broader diagnostic conceptualisation show that the majority of patients have a disabling and chronic disorder. Conceptualising and handling MDD as a narrowly defined and episodic disorder may underestimate the prognosis of the majority of depressed patients and, consequently, the type of care that is appropriate. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0972-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5725897
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57258972017-12-13 Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule Verduijn, Judith Verhoeven, Josine E. Milaneschi, Yuri Schoevers, Robert A. van Hemert, Albert M. Beekman, Aartjan T. F. Penninx, Brenda W. J. H. BMC Med Research Article BACKGROUND: Major depressive disorder (MDD) is often handled as an episodic and isolated disorder, resulting in an optimistic view about its prognosis. Herein, we test the idea that the prognosis of MDD changes if we vary the perspective in terms of (1) a longer time frame and (2) a broader diagnostic conceptualisation including dysthymia, (hypo)mania and anxiety disorders as relevant outcomes. METHODS: Patients with current MDD at baseline (n = 903) and available 2-, 4-, and/or 6-year follow-up assessments were selected from the Netherlands Study of Depression and Anxiety, a psychiatric cohort study. Combining psychiatric DSM-IV-based diagnoses and life-chart data, patient course trajectories were classified as (1) recovered (no diagnoses at 2-year follow-up or thereafter), (2) recurrent without chronic episodes, (3) recurrent with chronic episodes or (4) consistently chronic since baseline. A chronic episode was defined as having a current diagnosis at the follow-up assessment and consistent symptoms over 2 years. Proportions of course trajectories were provided moving from a short, narrow perspective (2-year follow-up, considering only MDD diagnosis) to a long, broad perspective (6-year follow-up, including MDD, dysthymia, (hypo)mania and anxiety diagnoses). RESULTS: With the short, narrow perspective, the recovery rate was 58% and 21% had a chronic episode. However, in the long, broad perspective the recovery rate was reduced to 17%, while 55% of the patients experienced chronic episodes. CONCLUSIONS: Results from a long and rigorous follow-up in a large cohort suggests that most MDD patients have an unfavourable prognosis. Longer follow-up and broader diagnostic conceptualisation show that the majority of patients have a disabling and chronic disorder. Conceptualising and handling MDD as a narrowly defined and episodic disorder may underestimate the prognosis of the majority of depressed patients and, consequently, the type of care that is appropriate. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0972-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-12 /pmc/articles/PMC5725897/ /pubmed/29228943 http://dx.doi.org/10.1186/s12916-017-0972-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Verduijn, Judith
Verhoeven, Josine E.
Milaneschi, Yuri
Schoevers, Robert A.
van Hemert, Albert M.
Beekman, Aartjan T. F.
Penninx, Brenda W. J. H.
Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
title Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
title_full Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
title_fullStr Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
title_full_unstemmed Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
title_short Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
title_sort reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725897/
https://www.ncbi.nlm.nih.gov/pubmed/29228943
http://dx.doi.org/10.1186/s12916-017-0972-8
work_keys_str_mv AT verduijnjudith reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule
AT verhoevenjosinee reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule
AT milaneschiyuri reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule
AT schoeversroberta reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule
AT vanhemertalbertm reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule
AT beekmanaartjantf reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule
AT penninxbrendawjh reconsideringtheprognosisofmajordepressivedisorderacrossdiagnosticboundariesfullrecoveryistheexceptionratherthantherule